SEC Form 4 · accession 0001179110-15-015619
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen M Dow
Director
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2015 | S | 88 | $37.11 | D | 0 | I | See Footnote |
| Common StockF2 | holding | — | — | — | 282,190 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 88 common shares sold by SRB Associates IX L.P. ("SRBAIX") in a single transaction. Reporting person is a member of the general partner of SRBAIX and disclaims beneficial ownership except to the extent of his proportionate interest in these shares.
- F2Represents total common shares owned directly by The Dow Family Trust ("Dow Trust"). Reporting person is a trustee of the Dow Trust.